Phase 1 study of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in breast cancer patients after autologous peripheral blood progenitor cell (PBPC) transplantation.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples